The Lancet Global Health in conversation with

Senjuti Saha on the health-care burden of RSV in Bangladesh


Listen Later

In a resource-constrained setting like Bangladesh, what proportion of a hospital's capacity is taken up with admissions for respiratory syncytial virus (RSV)? How many children needing admission are turned away every year because of lack of bed space? And how many of these "denials" and subsequent deaths might be prevented by the introduction of a maternal RSV vaccine or the monoclonal antibody nirsevimab? 

Listen to Senjuti Saha, Deputy Executive Director of the Child Health Research Foundation, describe the results of her fascinating and potentially policy-changing study to our Editor-in-Chief, Zoë Mullan.

Read the full article:

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00048-8/fulltext?dgcid=buzzsprout_icw_podcast_May_25_langlo

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Global Health in conversation withBy The Lancet Group

  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings


More shows like The Lancet Global Health in conversation with

View all
Economist Podcasts by The Economist

Economist Podcasts

4,283 Listeners

The Lancet Voice by The Lancet Group

The Lancet Voice

23 Listeners

The Lancet Child & Adolescent Health in conversation with by The Lancet Group

The Lancet Child & Adolescent Health in conversation with

0 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

2 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

1 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Healthy Longevity in conversation with by The Lancet Group

The Lancet Healthy Longevity in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners